Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pegvaliase

pegvaliase
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Palynziq INJECTION, SUBCUTANEOUS 2.5 mg/0.5 mL, 10 mg/0.5 mL, 20 mg/1 mL      
Comments:

Initiation should be deferred until after hospital discharge when patient can be enrolled in a complicated REMS program and with at least first dose administered in physician's office. Inpatients may use own supply.

Reviewed: August 2020 (Palynziq)

Last updated: Aug. 31, 2020






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved